Issue: January 2017
January 10, 2017
1 min read
Save

Trial Scorecard: ATHENA-HF

Issue: January 2017
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Study of the effect of high-dose spironolactone on outcomes including N-terminal pro-B type natriuretic peptide levels in patients with acute HF.

Trial Scorecard: ATHENA-HF